Kadriye Işıl
Berker
a,
Kubilay
Güçlü
b,
Birsen
Demirata
a and
Reşat
Apak
*b
aDepartment of Chemistry, Faculty of Science and Letters, Istanbul Technical University, Ayazaga Maslak, 34469, Istanbul, Turkey
bDepartment of Chemistry, Faculty of Engineering, Istanbul University, Avcilar, 34320, Istanbul, Turkey. E-mail: rapak@istanbul.edu.tr; Fax: +90-212-4737180; Tel: +90-212-4737028
First published on 21st September 2010
Since antioxidants are health-beneficial compounds capable of removing reactive species, assay of total antioxidant capacity (TAC) by simple and low-cost methods is important. The magenta-coloured iron(II)-ferrozine (Fe(II)-FZ) complex showing an absorbance maximum at 562 nm has previously been utilized for iron-binding assays, but not for antioxidant determination. Ferrozine is a highly ferrous-stabilizing ligand such that ferric ion in the presence of ferrozine easily oxidizes antioxidants and is itself reduced to Fe(II)-FZ, yielding a very high molar absorptivity and thus enhanced sensitivity for most antioxidants. The hierarchic order of antioxidant power for common antioxidants was in accordance with known structure–activity relationships. The Fe(III)-FZ assay was applied to synthetic antioxidant mixtures to yield additive absorbance values, which is a prerequisite for precise determination of antioxidant capacity of complex mixtures. The calibration curves (lines) of trolox and quercetin individually and in herbal infusions—by using the method of standard additions—were parallel, confirming that the herbal antioxidants and trolox did not chemically interact among each other so as to cause apparent deviations from Beer's law. The proposed method was applied to medicinal plant infusions for total antioxidant capacity assay as trolox-equivalents, and the results were compared to those found with CUPRAC (cupric reducing antioxidant capacity), FRAP (ferric reducing antioxidant power) and Folin total phenols assays, the highest correlation being achieved with CUPRAC. In short, a novel ferric reducing assay for food antioxidants was introduced, which was superior to FRAP in regard to its realistic pH, enhanced sensitivity, faster kinetics, and absence of free Fe(II)—which can cause Fenton-type oxidations—in the reaction products.
A variety of assays have been used to measure the total antioxidant capacity (TAC) of pure substances, food extracts, and beverages.4 Some representative assays are 2,2′-azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS)/trolox-equivalent antioxidant capacity (TEAC),5,6 Folin-Ciocalteu total phenols,7 ferric reducing antioxidant power (FRAP),8–10 ferricyanide/Prussian blue method,11 cupric reducing antioxidant capacity (CUPRAC),12–14 cerium(IV) reducing antioxidant capacity,15 and 2,2-diphenyl-1-picrylhydrazyl radical scavenging capacity (DPPH)16 methods. These methods are either ET (electron transfer)—based or a mixture of ET—and hydrogen atom transfer (HAT)-based assays in mechanism, measuring the absorbance difference of an oxidant reagent (at a prespecified wavelength) during the course of the oxidation of an antioxidant.
Stookey used the disodium salt of 3-(2-pyridyl)-5,6-bis(4-phenylsulfonic acid)-1,2,4-triazine (known as ferrozine: FZ) for determination of iron(II) in acetic acid/sodium acetate buffer medium at pH 5.5.17 The molar absorptivity found by Stookey17 for the Fe(FZ)34− chelate was ε = 2.8 × 104 L mol−1cm−1 at 562 nm, with notable interference from only oxalate, nitrite, and cyanide. Pascual-Ruguera et al. used ferrozine for the sensitive and reproducible flow-injection (FI) spectrophotometric analysis of iron.18 Molina-Diaz et al. used ferrozine in hexamethylenetetramine–buffered medium at pH 5.5 as a reagent for indirect FI-determination of ascorbic acid after its oxidation with Fe(III) in acid solution.19 Giokas et al. used ferrozine for speciation of Fe(II) and Fe(III) by using FI-spectrophotometry, and flame-AAS after cloud-point extraction.20 Ferrozine has generally been used in literature in the assay of iron or ‘iron binding capacity’ of food and human serum.21,22 Among many examples of Fe(II) binding measurement, ferrozine has been used by Gülçin et al. (2003),23 Gülçin (2007),24 Ak and Gülçin (2008)25 as a reagent for determining ‘ferrous ion chelating activity’ of phenolic compounds and plant extracts via measuring the percentage inhibition of ferrozine-Fe2+ complex, in accordance with the modified method of Dinis et al. (1994).26
A variety of ligands have been used in iron(III)-based assays in the determination of TAC or reducing capacity. These are 1,10-phenanthroline, 4,7-diphenyl-1,10-phenanthroline (batho-phenanthroline), 2,4,6-tris(2-pyridyl)-1,3,5-triazine(TPTZ),8,27 and ferricyanide.11 The most widely used ferric reducing antioxidant assay, FRAP, was extensively criticised for its unrealistic pH of 3.6 (where most phenolics would not dissociate their protons, and thus would be less susceptible to oxidative attack by the assay reagent), relatively slow kinetics which do not enable the completion of oxidation of certain hydroxycinnamic acids and thiols within the protocol time period of the assay, and higher affinity toward hydrophilic antioxidants than hydrophobic ones.28 Moreover, since the (Fe(III)/TPTZ) mole ratio in the FRAP reagent exceeds the stoichiometric value of complex formation, the associated redox reaction with antioxidants may produce unbound (free) Fe(II) which is suspected to cause redox cycling of antioxidants during the assay as a result of Fe(II)-mediated Fenton-type reactions.29 No assay has been reported in literature capable of measuring TAC through iron(III) reduction in the presence of ferrozine. Ferrozine is a partially selective and very sensitive reagent for Fe(II) which may emerge as a result of reduction of ferric ion by antioxidants, and the stoichiometric reaction ratio between Fe(II) and ferrozine is 1:3.17,19
In this study, we measured TAC with the use of ferric-ferrozine reagent. The visible absorption spectrum of the ferrous complex of ferrozine exhibits a single sharp absorption peak with maximum absorbance at λmax = 562 nm. The TAC assay proceeds via reduction of Fe(III) to Fe(II), and subsequent determination of the formed Fe(II) with ferrozine using spectrophotometric absorbance measurement at λmax. The advantages of ferrozine over other iron-based TAC assays are higher molar absorptivity,17 relatively lower interference from foreign ions,17 wide pH tolerance,17 complex stability constant as high as β3 = 3.4 × 1015,30 water solubility, and low viscosity.19 The molar absorptivity is so high (at the order of 2.8 × 104 L mol−1cm−1)17 that quite low concentrations of antioxidants can be determined. The maximum absorption wavelength is quite different from those characteristic of plant pigments, enabling the interference-free measurement of TAC of plant food. By forming a stable iron(II)-chelate, a plant extract with a high antioxidant power strongly reduces the free ferrous ion concentration with the aid of ferrozine thereby decreasing the probability of a Fe(II)-based Fenton reaction31 which is common to many iron–based assays32 The standard redox potential of the Fe3+/Fe2+ couple at the order of 0.77 V should be shifted to distinctly more positive potentials due to selective complexation of ferrous ions in preference to the ferric state, enabling the oxidation of antioxidants acting as weak reductants. Another advantage of the proposed method is that incubation (at a higher temperature) is not required. Gibbs suggested that in an aqueous solution with a pH of 3–6 and a temperature range of 10°–45 °C, a 5-min colour development would normally be adequate for ± 2% accuracy in iron determination.30 Since use of hexamethylenetetramine buffer at pH 5.5 causes precipitation, acetic acid/sodium acetate buffer is preferred.
The proposed assay depends on the reduction of a ferric-ferrozine reagent with antioxidants to the stable ferrous-ferrozine chelate in buffered medium. The apparent molar absorptivity, linear concentration range and TEAC (trolox equivalent antioxidant capacity) values of the studied antioxidants were found in the proposed assay. Additivity of TAC values of individual antioxidants in the proposed method were tested for synthetic mixtures, and the found antioxidant capacities of certain medicinal plant extracts were compared with those of other similar assays.
Antioxidant capacity methods | The apparent molar absorptivity of trolox/L mol−1cm−1 |
---|---|
Ferric-ferrozine method | ε TR = 6.01 × 104 |
CUPRAC method | ε TR = 1.67 × 104 |
FRAP method | ε TR = 4.62 × 104 |
Folin-Ciocalteau method | ε TR = 4.65 × 103 |
The TAC value of an unknown sample (in the units of gram-trolox equivalent antioxidant content per g-weight of sample) was calculated as follows: If a herbal infusion or extract (initial volume = Vcup) prepared from (m) g dry matter was diluted (r) times prior to analysis, and a sample volume of (Vs) was taken for analysis from the diluted extract, and colour development (after addition of reagents) was made in a final volume (Vf) to yield an absorbance (Af), then the total antioxidant capacity (TAC) of the herb (mmol TR/g dry matter, or simply mmol TR/g) was found using the equation: TAC (mmol TR/g) =(Af/εTR) × (Vf/Vs) × r(Vcup/m).33
The calculation of expected and found antioxidant capacity (in the units of mM TR-equivalent) of synthetic mixtures was performed as follows: Possible binary, ternary and quaternary mixtures of antioxidant compounds were synthetically prepared, and the suitably diluted solutions were analyzed for TAC using the proposed ferric-ferrozine method. Since 1-cm optical cells were used in absorbance measurements, the experimental TAC was found by dividing the measured absorbance to the apparent molar absorptivity of trolox (εTR) measured under identical conditions of the given assay, and multiplying the quotient by 1000. The theoretical TAC of the synthetic mixture was calculated using eqn (1) where 1,2,…, i denote the corresponding constituents of the mixture
(TAC)expected = (TEAC)1 (concn)1 + (TEAC)2 (concn)2 + … + (TEAC)n (concn)n | (1) |
TEACFRAP = 0.701 TEACferric-ferrozine + 0.222 (r = 0.982) |
TEACABTS = 1.12 TEACferric-ferrozine + 0.444 (r = 0.932) |
Antioxidants | Slope × 10−4 | Intercept × 102 | LCR × 105 | Correlation coefficient | TEAC |
---|---|---|---|---|---|
Trolox (TR) | 6.01 | 1.34 | 0.3–0.6 | 0.9992 | 1.00 |
Ascorbic acid (AA) | 6.07 | 1.21 | 0.3–0.6 | 0.9994 | 1.01 |
Caffeic acid (CF) | 7.42 | 4.56 | 0.3–0.6 | 0.9998 | 1.23 |
Ferulic acid (FR) | 5.52 | −2.37 | 0.3–0.6 | 0.9994 | 0.92 |
Gallic acid (GA) | 15.8 | −6.47 | 0.2–0.7 | 0.9996 | 2.63 |
Quercetin (QR) | 21.9 | −7.01 | 0.1–0.5 | 0.9992 | 3.64 |
Rutin (RT) | 9.02 | −0.93 | 0.2–1.3 | 0.9999 | 1.50 |
Catechin (CT) | 7.95 | −1.66 | 0.2–1.3 | 0.9999 | 1.32 |
Rosmarinic acid (RA) | 15.9 | −2.44 | 0.1–0.7 | 0.9998 | 2.65 |
Ellagic acid (EA) | 14.7 | −0.88 | 0.1–0.8 | 0.9983 | 2.45 |
Glutathione (GSH) | 1.43 | −17.7 | 1.5–7.7 | 0.9990 | 0.24 |
Cysteine (CYS) | 3.03 | −5.23 | 1.1–8.8 | 0.9997 | 0.50 |
Since FRAP is a ferric reducing assay of similar (ET: electron transfer) mechanism to that of the ferric-ferrozine assay, it showed a higher correlation compared to the ABTS assay which is considered to be a mixed ET- and HAT-based method. A further advantage to ABTS may be the TEAC coefficient of cysteine which was measured by the proposed method as 0.5, corresponding to its physiological role as reversible 1−e oxidation to cystine. The ABTS/persulfate antioxidant assay method was shown to treat GSH as a reductant capable of giving ≥ 2 electrons (TEAC of ABTS/persulfate method for GSH varied between 1.3 and 1.5).13 However, reversible oxidation reactions of protein thiols as a part of antioxidant action involving two- or more electrons are less likely in vivo.35
The hierarchy of antioxidant power involves some structure–activity relationships, discussed in detail by Apak et al.28 According to kinetic studies of aryloxy (Ar–O˙) radical formation and decomposition reactions, the antioxidant activity (AOA) of a flavonoid is closely related to its chemical structure. Three structural requirements are important for high AOA of a flavonoid.36
(i) the ortho-dihydroxy (catechol) structure in the B-ring, imparting a greater stability to the formed aryloxy radicals as a result of flavonoid oxidation, possibly through H-bonding and electron-delocalization.37 Another function of the catechol moiety in the B-ring is the possible chelation of transition metal ions that may otherwise cause ROS formation via Fenton-type reactions;36
(ii) the 2,3-double bond, in conjugation with the 4-oxo function, enhancing electron-transfer and radical scavenging actions through electron-delocalization;36
(iii) the presence of both 3- and 5-OH groups, enabling the formation of stable quinonic structures upon flavonoid oxidation.38 Substitution of the 3-OH results in increase in tortion angle and loss of coplanarity, and subsequently reduced AOA.39 A typical flavonoid which meets the above three criteria is quercetin, showing the highest antioxidant capacity in both the proposed method and CUPRAC.
Aside from these structural requirements, the number of hydroxyl substituents on the flavonoid molecule, the position of these hydroxyls, the presence of glycosides (–OR) or aglycons (–OH), and the overall degree of conjugation are important in determining AOA28,40 applying for the medium power antioxidants RT and CT. For hydroxycinnamic acids, the number of phenolic –OH groups is important, and thus, caffeic acid having two –OH substituents should have a higher AOA than one –OH bearing ferulic acid.41 Likewise, rosmarinic acid having four phenolic –OH groups in a perfectly conjugated molecule should exhibit the highest AOA among hydroxycinnamic acids28 which is the case for both the proposed method and CUPRAC (Fig. 1).
Fig. 1 UV-visible absorption spectra of reduced iron-ferrozine (Fe(II)-FZ) complex as a result of redox reaction with varying concentrations of trolox. |
The expected and found total antioxidant capacities (TAC, as mM trolox-equivalent) of binary, ternary and quaternary synthetic mixtures of antioxidants using the proposed ferric-ferrozine assay are shown in Table 3, verifying the additivity of TAC values of constituents forming the mixtures. The proposed method was also applied to green tea, nettle tea, ceylon tea, linden, chamomile, mint and sage herbal tea as real sample solutions of complex nature. The calibration curves of QR in pure aqueous solution and in two selected herbal tea (green tea and nettle) infusions were parallel to each other (Fig. 2), and the same was observed for TR (figure not shown). The calibration lines of trolox (TR) in different media, namely alone, in nettle infusion having an initial absorbance of A562nm = 0.161, and in green tea infusion having an initial absorbance of A562nm = 0.240): TR alone; A = 1.34 × 10−2 + 6.01 × 104CTR, TR in nettle infusion; A = 1.65 × 10−1 + 6.04 × 104CTR, and TR in green tea infusion; A = 2.48 × 10−1 + 6.03 × 104CTR. The obtained calibration lines of the tested antioxidants in pure solution and in the real sample extracts showed good parallelism. A similar parallelism was observed for the calibration curves of CF in QR solution, and of FR in TR solution (figures not shown). These findings verified that in the proposed ferric-ferrozine assay of TAC, either antioxidant compounds among themselves or constituents of real matrix solutions with pure antioxidants did not show chemical interactions so as to cause a chemical deviation from Beer's law disrupting the additivity of optical absorbances. This means the TAC of real mixtures measured with the proposed method is approximately equal to the sum of TAC values of constituents forming the mixture, an essential property in reliable comparison of TAC of food matrices.
Composition of mixture | Capacity expected | Capacity found | Composition of mixture | Capacity expected | Capacity found | ||
---|---|---|---|---|---|---|---|
RT | (3 × 10−4 M 30 μL) | 7.40 × 10−3 | 8.94 × 10−3 | QR | (3 × 10−4 M 20 μL) | 8.95 × 10−3 | 8.35 × 10−3 |
CA | (3 × 10−4 M 50 μL) | CF | (3 × 10−4 M 50 μL) | ||||
GA | (3 × 10−4 M 30 μL) | 9.66 × 10−3 | 1.08 × 10−2 | QR | (3 × 10−4 M 20 μL) | 8.12 × 10−3 | 7.96 × 10−3 |
CA | (3 × 10−4 M 50 μL) | EA | (3 × 10−4 M 20 μL) | ||||
RA | (3 × 10−4 M 20 μL) | 7.24 × 10−3 | 9.39 × 10−3 | TR | (3 × 10−4 M 50 μL) | 7.92 × 10−3 | 8.36 × 10−3 |
FR | (3 × 10−4 M 75 μL) | FR | (3 × 10−4 M 75 μL) | ||||
CF | (3 × 10−4 M 50 μL) | 1.27 × 10−2 | 1.20 × 10−2 | CF | (3 × 10−4 M 50 μL) | 1.20 × 10−2 | 9.87 × 10−3 |
TR | (3 × 10−4 M 50 μL) | FR | (3 × 10−4 M 75 μL) | ||||
GA | (3 × 10−4 M 30 μL) | TR | (3 × 10−4 M 50 μL) | ||||
RA | (3 × 10−4 M 20 μL) | 1.05 × 10−2 | 1.03 × 10−2 | AA | (3 × 10−4 M 50 μL) | 1.27 × 10−2 | 1.29 × 10−2 |
FR | (3 × 10−4 M 75 μL) | CF | (3 × 10−4 M 50 μL) | ||||
TR | (3 × 10−4 M 50 μL) | GA | (3 × 10−4 M 30 μL) | ||||
RA | (3 × 10−4 M 20 μL) | 1.06 × 10−2 | 1.19 × 10−2 | RA | (3 × 10−4 M 20 μL) | 1.00 × 10−2 | 9.27 × 10−3 |
FR | (3 × 10−4 M 75 μL) | AA | (3 × 10−4 M 50 μL) | ||||
TR | (3 × 10−4 M 50 μL) | CF | (3 × 10−4 M 50 μL) | ||||
TR | (3 × 10−4 M 50 μL) | 1.08 × 10−2 | 1.15 × 10−2 | TR | (3 × 10−4 M 50 μL) | 1.09 × 10−2 | 1.00 × 10−2 |
QR | (3 × 10−4 M 20 μL) | RT | (3 × 10−4 M 30 μL) | ||||
RA | (3 × 10−4 M 20 μL) | FR | (3 × 10−4 M 75 μL) | ||||
GA | (3 × 10−4 M 30 μL) | 1.25 × 10−2 | 1.39 × 10−2 | AA | (3 × 10−4 M 50 μL) | 1.20 × 10−2 | 1.18 × 10−2 |
RA | (3 × 10−4 M 20 μL) | CF | (3 × 10−4 M 50 μL) | ||||
FR | (3 × 10−4 M 75 μL) | FR | (3 × 10−4 M 75 μL) | ||||
QR | (3 × 10−4 M 20 μL) | 1.34 × 10−2 | 1.58 × 10−2 | RT | (3 × 10−4 M 30 μL) | 1.15 × 10−2 | 1.26 × 10−2 |
CA | (3 × 10−4 M 50 μL) | CA | (3 × 10−4 M 50 μL) | ||||
CF | (3 × 10−4 M 50 μL) | CF | (3 × 10−4 M 50 μL) | ||||
GA | (3 × 10−4 M 30 μL) | 1.27 × 10−2 | 1.57 × 10−2 | GA | (3 × 10−4 M 30 μL) | 1.24 × 10−2 | 1.61 × 10−2 |
CA | (3 × 10−4 M 50 μL) | RT | (3 × 10−4 M 30 μL) | ||||
RT | (3 × 10−4 M 30 μL) | CF | (3 × 10−4 M 50 μL) | ||||
QR | (3 × 10−4 M 20 μL) | 1.45 × 10−2 | 1.47 × 10−2 | TR | (3 × 10−4 M 50 μL) | 1.42 × 10−2 | 1.46 × 10−2 |
GA | (3 × 10−4 M 30 μL) | RT | (3 × 10−4 M 30 μL) | ||||
CA | (3 × 10−4 M 50 μL) | RT | (3 × 10−4 M 30 μL) | ||||
AA | (3 × 10−4 M 50 μL) | ||||||
RA | (3 × 10−4 M 20 μL) | 1.37 × 10−2 | 1.30 × 10−2 | ||||
AA | (3 × 10−4 M 50 μL) | ||||||
CA | (3 × 10−4 M 50 μL) | ||||||
TR | (3 × 10−4 M 50 μL) |
Fig. 2 Calibration line of quercetin (QR) in pure aqueous solution, in green tea infusion, and in nettle infusion with respect to the ferric-ferrozine method. QR alone A = −7.01 × 10−2 + 2.19 × 105CQR, QR in nettle infusion A = 1.46 × 10−1 + 2.02 × 105CQR, QR in green tea infusion A = 2.88 × 10−1 + 2.02 × 105CQR. |
The TAC values of these herbal tea extracts were measured in the units of mmol TR/g (Table 4). The TAC values of these real extracts, as assayed by the proposed ferric-ferrozine and reference antioxidant assay methods, showed the following binary correlations:
TACCUPRAC = 1.19 TACFe(III)-ferrozine + 0.063 (r = 0.966) |
TACFRAP = 0.386 TACFe(III)-ferrozine + 0.108 (r = 0.888) |
TACFolin = 0.560 TACFe(III)-ferrozine + 0.275 (r = 0.862) |
Extracted medicinal plants | Ferric-Ferrozine | CUPRAC | FRAP | Folin-Ciocalteu |
---|---|---|---|---|
Nettle tea, (Urtica diocia/urens) | 1.46 × 10−1 | 3.26 × 10−1 | 1.17 × 10−1 | 2.76 × 10−1 |
Mint, (Mentha piperita) | 1.33 × 10−1 | 1.17 × 10−1 | 2.54 × 10−1 | 4.64 × 10−1 |
Chamomile, (Matricaria chamomilla L.) | 6.69 × 10−2 | 1.17 × 10−1 | 5.52 × 10−2 | 1.85 × 10−1 |
Sage herbal tea, (Salvia officinalis) | 3.12 × 10−1 | 6.0 × 10−1 | 2.74 × 10−1 | 5.38 × 10−1 |
Linden, (Tilia) | 1.34 × 10−2 | 2.76 × 10−2 | 1.13 × 10−1 | 3.35 × 10−1 |
Green tea, (Camellia sinensis) | 6.32 × 10−1 | 7.52 × 10−1 | 3.72 × 10−1 | 5.34 × 10−1 |
Ceylon tea, (Camellia sinensis) | 7.80 × 10−1 | 9.76 × 10−1 | 3.73 × 10−1 | 7.59 × 10−1 |
These TAC relationships reveal that the best correlation and one-to-one correspondence to the proposed assay is supplied by the CUPRAC assay also based on the same principle of reducing power measurement. Both the proposed ferric ferrozine and the widely used CUPRAC assays are electron-transfer (ET)-based assays, producing coloured species when the corresponding reagents are reduced by antioxidants. In literature, it has been observed that the results of ET-based assays show a much better agreement among themselves than with those of HAT–based assays, due to the similarity in mechanism. In regard to kinetics, the CUPRAC reagent is fast enough to oxidize thiol-type antioxidants, whereas according to the protocol developed by Benzie and Strain,8 the FRAP method does not measure thiol-type antioxidants like glutathione42 and slowly responds to certain hydroxycinnamic acids.28 The reason for this may be the half-filled d-orbitals of high spin Fe(III) attributing it a chemical inertness, while the electronic structure of Cu(II) enables fast kinetics. Another reason for this difference between the kinetic behaviours of Fe(III) and Cu(II) toward thiols may be the softer character (with respect to the “Hard and Soft Acids and Bases”, HSAB Theory) of Cu(II) enabling the coordination of the latter to the soft –SH groups as the electron donor. However, in spite of these kinetic differences, the proposed assay gave a close agreement with CUPRAC, showing that the higher stabilization of ferrous ion in the presence of ferrozine probably provides faster kinetics for Fe(III) oxidation of a number of antioxidants than the conventional FRAP assay.
Fig. 3 The change of absorbance of cysteine, glutathione, caffeic acid, and ferulic acid as a function of time (oxidant: ferric ferrozine reagent). |
When the apparent molar absorptivities of quercetin and ferulic acid as a result of ferric ferrozine oxidation in media of different ethanol contents (being progressively varied from 50% to 100% EtOH) were examined, the relative change was within 7% for ferulic acid and 9% for quercetin, demonstrating that the composition of alcohol-aqueous mixtures do not have a significant effect on the formation of the ferrous ferrozine chromophore (table not shown). So, the proposed methodology can easily assay antioxidants from plant extracts containing different levels of alcohol, without a special consideration for the composition of extracting solvent mixture.
A second advantage is that this new reagent (FZ) for a modified ferric reducing assay provides a very high apparent molar absorptivity for antioxidants (e.g., ε = 6.0 × 104 Lmol−1cm−1 for trolox and ascorbic acid), and therefore enhanced sensitivity in total antioxidant capacity (TAC) measurement. Since most laboratories dealing with plant antioxidants already use the FZ reagent for ‘iron-binding capacity’ assays, this reagent may also be used for an additional aim of TAC measurement in such laboratories. The proposed method is easy, flexible, and of low-cost. The extremely high sensitivity provided by the proposed assay (due to preferential stabilization of divalent iron over trivalent iron by ferrozine) may also be advantage for on-line HPLC applications using a chromogenic derivatizing agent in the post-column mode,47 because in post-column applications, only authentically antioxidant compounds give a signal, often with weak sensitivity, and very sensitive indirect methods of antioxidant characterization need to be used in such assays.
A third advantage over FRAP may be the relatively stronger chelation of ferrous ion—produced as a result of reaction with antioxidants—using ferrozine, hindering Fenton-type reactions.48 The FRAP reagent contains excessive Fe(III)—higher than the stochiometric ratio required for complex formation—compared to the ferric ferrozine reagent. As a result, some free Fe(II) accompanying Fe(II)-TPTZ chelate may form after the reaction with antioxidants. The FRAP method was previously criticised for producing Fe(II) which may cause redox cycling of antioxidants during the assay as a result of Fe(II)-mediated Fenton-type reactions.29
A fourth advantage is that the near-neutral pH of this work (pH 5.5) is significantly higher than that of the widely used FRAP test having a working pH of 3.6. As the solubility product of ferric hydroxide is very low, i.e., Ksp [Fe(OH)3] = 6.0 × 10−38, ferric ion-based assays are usually performed at low pH to prevent the hydrolysis of Fe(III), which would otherwise lower the Fe(III)/Fe(II) potential and consequently obstruct the oxidation of antioxidants by the ferric-based reagent. The acidic medium of FRAP is rather unrealistic (pH 3.6) in regard to simulation of antioxidant action under physiological conditions, because at significantly more acidic conditions than the physiological pH, the reducing capacity may be suppressed due to protonation on antioxidant compounds. Another widely used antioxidant test is the Folin phenolics assay, which provides a redox reaction at pH 10, again not in accordance with physiological requirements. Therefore, a pH of 5.5 should not be considered out of biological relevance. Such a high (near-neutral) pH in conjunction with a ferric-based reagent in the proposed assay was only possible by virtue of extra stabilization of the ferrous state by ferrozine complexation.
The only possible disadvantage compared to FRAP may be the higher redox potential of the ferric ferrozine reagent due to extreme stabilization of the lower oxidation state of iron. However, higher potential compounds such as the food preservative citric acid (which is not classified as a true antioxidant) has been shown in this work not to be oxidized by the ferric ferrozine reagent at 5-fold concentrations (i.e., 5.0 × 10−2 mM).
This journal is © The Royal Society of Chemistry 2010 |